Inovio Pharmaceuticals PT Raised to $4.00 (INO)

Share on StockTwits

Equities research analysts at Brean Capital raised their price target on shares of Inovio Pharmaceuticals (NYSE:INO) from $3.00 to $4.00 in a research note issued to investors on Friday, ARN reports. The firm currently has a “buy” rating on the stock. Brean Capital’s target price would suggest a potential upside of 58.10% from the company’s current price.

Separately, analysts at Aegis reiterated a “hold” rating on shares of Inovio Pharmaceuticals in a research note to investors on Wednesday, November 13th. They now have a $2.50 price target on the stock.

Inovio Pharmaceuticals (NYSE:INO) opened at 2.53 on Friday. Inovio Pharmaceuticals has a 52 week low of $0.49 and a 52 week high of $3.03. The stock has a 50-day moving average of $2.38 and a 200-day moving average of $2.01. The company’s market cap is $527.2 million.

Inovio Pharmaceuticals (NYSE:INO) last announced its earnings results on Monday, November 11th. The company reported ($0.16) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.02) by $0.14. The company had revenue of $9.50 million for the quarter, compared to the consensus estimate of $2.99 million. On average, analysts predict that Inovio Pharmaceuticals will post $-0.31 earnings per share for the current fiscal year.

Inovio Pharmaceuticals, Inc, formerly Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of vaccines, called deoxyribonucleic acid (NYSE:INO) vaccines, focused on cancers and infectious diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Novartis, GlaxoSmitheKline and Eli Lilly Announce Deals
Novartis, GlaxoSmitheKline and Eli Lilly Announce Deals
Chobani Moving Beyond Just Greek Yogurt
Chobani Moving Beyond Just Greek Yogurt
IBM Reports Drop In Revenue And Profit
IBM Reports Drop In Revenue And Profit
Google Fails To Meet Expectations In First Quarter
Google Fails To Meet Expectations In First Quarter
Shipments of Xbox One Surpass Five Million
Shipments of Xbox One Surpass Five Million
Yahoo Revenue and Earnings Beat the Street
Yahoo Revenue and Earnings Beat the Street


Leave a Reply

 
© 2006-2014 Zolmax. Subscribe